EdgarLookup

AN2 Therapeutics, Inc. — 3 Filings

20 3 filings on record

This page lists all 3 filings submitted to the SEC by AN2 Therapeutics, Inc. (ANTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. AN2 Therapeutics, Inc. has filed 20 3 documents with the SEC since 2021. To view all SEC filings by AN2 Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 144 3 3/A 4 4/A 424B4 424B5 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT PRE 14A S-1 S-1/A S-1MEF S-3 S-8 SC 13G SC 13G/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
3 3 0001193125-26-036046 Feb 3, 2026 Jan 26, 2026
3 3 0000950170-24-121585 Nov 5, 2024 Nov 4, 2024
3 0001373604-24-000064 Aug 12, 2024 Aug 9, 2024
3 FORM 3 SUBMISSION 0000899243-22-033045 Oct 5, 2022 Sep 29, 2022
3 FORM 3 SUBMISSION 0000899243-22-017369 May 9, 2022 May 5, 2022
3 FORM 3 SUBMISSION 0000899243-22-012182 Mar 24, 2022
3 FORM 3 SUBMISSION 0000899243-22-012181 Mar 24, 2022
3 FORM 3 SUBMISSION 0000899243-22-012180 Mar 24, 2022
3 FORM 3 SUBMISSION 0000899243-22-012179 Mar 24, 2022
3 FORM 3 SUBMISSION 0000899243-22-012175 Mar 24, 2022
3 FORM 3 SUBMISSION 0000899243-22-012174 Mar 24, 2022
3 FORM 3 SUBMISSION 0000899243-22-012173 Mar 24, 2022
3 OWNERSHIP DOCUMENT 0001104659-22-037672 Mar 24, 2022
3 FORM 3 SUBMISSION 0000899243-22-012170 Mar 24, 2022
3 FORM 3 SUBMISSION 0000899243-22-012167 Mar 24, 2022
3 FORM 3 SUBMISSION 0000899243-22-012164 Mar 24, 2022
3 FORM 3 SUBMISSION 0000899243-22-012163 Mar 24, 2022
3 FORM 3 SUBMISSION 0000899243-22-012162 Mar 24, 2022
3 FORM 3 SUBMISSION 0000899243-22-012158 Mar 24, 2022
3 FORM 3 SUBMISSION 0000899243-22-012157 Mar 24, 2022